{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "The bill would have allowed biosimilar versions of biologic drugs to be substituted by pharmacists if the F.D.A. deemed them \u201cinterchangeable\u201d with the reference product.", "headline": {"main": "Gov. Brown of California Vetoes Biotech Drug Bill", "print_headline": "Gov. Brown of California Vetoes Biotech Drug Bill"}, "abstract": "California Gov Jerry Brown vetoes bill that would have allowed biosimilar versions of biologic drugs to be substituted by pharmacists if Food and Drug Administration deemed them 'interchangeable' with the brand-name reference product.", "print_page": "3", "word_count": "804", "_id": "525b30d67988105ad44f7948", "snippet": "The bill would have allowed biosimilar versions of biologic drugs to be substituted by pharmacists if the F.D.A. deemed them \u201cinterchangeable\u201d with the reference product.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2013/10/14/us/gov-brown-of-california-vetoes-biotech-drug-bill.html", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Health Insurance and Managed Care", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "California", "is_major": "Y", "rank": "1", "name": "glocations"}, {"value": "Generic Brands and Products", "is_major": "Y", "rank": "8", "name": "subject"}, {"value": "Biotechnology", "is_major": "Y", "rank": "6", "name": "subject"}, {"value": "Food and Drug Administration", "is_major": "N", "rank": "9", "name": "organizations"}, {"value": "Doctors", "is_major": "N", "rank": "7", "name": "subject"}, {"value": "Vetoes (US)", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Brown, Edmund G Jr", "is_major": "Y", "rank": "2", "name": "persons"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "4", "name": "subject"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Andrew", "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "document_type": "article", "pub_date": "2013-10-14T00:00:00Z", "section_name": "U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "Gov. Jerry Brown said the bill was premature because federal regulators had not even determined the standards governing the cheaper drugs.", "headline": {"main": "Governor Vetoes Bill to Limit Use of Generic Drugs in California", "print_headline": "Governor Vetoes Bill to Limit Use of Generic Drugs in California"}, "abstract": null, "print_page": "", "word_count": "846", "_id": "5259ea4d7988105ad44f7774", "snippet": "Gov. Jerry Brown said the bill was premature because federal regulators had not even determined the standards governing the cheaper drugs.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2013/10/13/us/governor-vetoes-bill-to-limit-use-of-generic-drugs-in-california.html", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "California", "is_major": "N", "rank": "2", "name": "glocations"}, {"value": "Biotechnology", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Brown, Edmund G Jr", "is_major": "N", "rank": "1", "name": "persons"}, {"value": "Generic Brands and Products", "is_major": "N", "rank": "6", "name": "subject"}, {"value": "Law and Legislation", "is_major": "N", "rank": "3", "name": "subject"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Andrew", "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "document_type": "article", "pub_date": "2013-10-13T00:00:00Z", "section_name": "U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "National", "lead_paragraph": "The high price of commonly used medications for conditions like asthma contributes heavily to health care costs and certainly causes more widespread anguish.", "headline": {"main": "The Soaring Cost of a Simple Breath", "kicker": "Paying Till It Hurts", "print_headline": "The Soaring Cost of a Simple Breath", "content_kicker": "Paying Till It Hurts"}, "abstract": "High price of commonly used medications for conditions like asthma, most common chronic disease that affects Americans of all ages, contributes heavily to health care costs; United States spends far more per capita on medicines than other countries, and drugs account for 10 percent of the nation's $2.7 trillion annual health bill (Series: Paying Till It Hurts).", "print_page": "1", "word_count": "3656", "_id": "52598e2b7988105ad44f76f7", "snippet": "The high price of commonly used medications for conditions like asthma contributes heavily to health care costs and certainly causes more widespread anguish.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2013/10/13/us/the-soaring-cost-of-a-simple-breath.html", "multimedia": [{"subtype": "wide", "url": "images/2013/10/13/us/JP-ASTHMA-6/JP-ASTHMA-6-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2013/10/13/us/JP-ASTHMA-6/JP-ASTHMA-6-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2013/10/13/us/JP-ASTHMA-6/JP-ASTHMA-6-articleLarge.jpg", "height": 357, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2013/10/13/us/JP-ASTHMA-6/JP-ASTHMA-6-articleLarge.jpg", "xlargeheight": "357"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2013/10/13/us/JP-ASTHMA-6/JP-ASTHMA-6-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2013/10/13/us/JP-ASTHMA-6/JP-ASTHMA-6-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Asthma", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "2", "name": "subject"}, {"value": "Prices (Fares, Fees and Rates)", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Series", "is_major": "Y", "rank": "4", "name": "subject"}, {"value": "Health Insurance and Managed Care", "is_major": "Y", "rank": "5", "name": "subject"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Elisabeth", "lastname": "ROSENTHAL"}], "original": "By ELISABETH ROSENTHAL"}, "document_type": "article", "pub_date": "2013-10-13T00:00:00Z", "section_name": "U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "The European Parliament, in a move favored by users and producers of electronic cigarettes, voted against regulating the products as medical devices.", "headline": {"main": "European Lawmakers Reject Tight Restrictions on E-Cigarettes", "print_headline": "European Lawmakers Reject Tight Restrictions on E-Cigarettes"}, "abstract": "European Parliament scraps proposals by health officials that electronic cigarettes be tightly regulated as medical devices, setting stage for debate in United States over extent of regulation; European lawmakers endorse permissive approach to sale and use of e-cigarettes.", "print_page": "1", "word_count": "1249", "_id": "5254045f7988105ad44f67bc", "snippet": "The European Parliament, in a move favored by users and producers of electronic cigarettes, voted against regulating the products as medical devices.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2013/10/09/business/international/european-lawmakers-reject-tight-restrictions-on-e-cigarettes.html", "multimedia": [{"subtype": "wide", "url": "images/2013/10/09/business/JP-ECIGS/JP-ECIGS-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2013/10/09/business/JP-ECIGS/JP-ECIGS-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2013/10/09/business/ECIG/ECIG-articleLarge.jpg", "height": 409, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2013/10/09/business/ECIG/ECIG-articleLarge.jpg", "xlargeheight": "409"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2013/10/09/business/ECIG/ECIG-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2013/10/09/business/ECIG/ECIG-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": "International Business", "keywords": [{"value": "Europe", "is_major": "Y", "rank": "5", "name": "glocations"}, {"value": "Smoking and Tobacco", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "European Parliament", "is_major": "N", "rank": "3", "name": "organizations"}, {"value": "Regulation and Deregulation of Industry", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Advertising and Marketing", "is_major": "N", "rank": "2", "name": "subject"}], "byline": {"contributor": "Andrew Higgins reported from Strasbourg, France, and Matt Richtel from San Francisco.", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Andrew", "lastname": "HIGGINS"}, {"organization": "", "role": "reported", "rank": 2, "firstname": "Matt", "lastname": "RICHTEL"}], "original": "By ANDREW HIGGINS and MATT RICHTEL"}, "document_type": "article", "pub_date": "2013-10-09T00:00:00Z", "section_name": "Business Day"}], "meta": {"hits": 4, "offset": 0, "time": 40}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}